Radiation therapy firm Accuray of Sunnyvale, CA, has received approval from the Japanese Ministry of Health, Labor and Welfare to market its CyberKnife G4 robotic radiosurgery system in Japan to treat tumors noninvasively anywhere in the body, including the head and neck.
The regulatory approval expands the types of patients that could be treated with radiosurgery to include those with cancers of the spine, lung, liver, pancreas, and prostate.
In June 2008, Accuray was granted approval of the CyberKnife system for use in Japan in the treatment of extracranial tumors, including tumors that move with respiration.
Related Reading
Siemens, Accuray join forces, June 9, 2010
Accuray reaches CyberKnife milestone, June 3, 2010
Accuray completes Colo. installation, May 28, 2010
Accuray taps Puppo for GM post, May 18, 2010
Accuray Q3 revenue slips, net income grows, May 7, 2010
Copyright © 2010 AuntMinnie.com
